Solid-phase Oligonucleotide Synthesis Market Insights, Global Outlook and Forecast 2022-2028
Solid-phase Oligonucleotide Synthesis Market Insights, Global Outlook and Forecast 2022-2028
The Solid phase Oligonucleotide Synthesis study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The latest research study released by Market IntelliX evaluates market size and forecasts of Solid-phase Oligonucleotide Synthesis in Global, including the following market information:
Global Solid-phase Oligonucleotide Synthesis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Solid-phase Oligonucleotide Synthesis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Primers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics and Gene Oracle, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Solid-phase Oligonucleotide Synthesis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Solid-phase Oligonucleotide Synthesis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Solid-phase Oligonucleotide Synthesis Market Segment Percentages, by Type, 2021 (%)
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Global Solid-phase Oligonucleotide Synthesis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Solid-phase Oligonucleotide Synthesis Market Segment Percentages, by Application, 2021 (%)
Commercial
Academic Research
Global Solid-phase Oligonucleotide Synthesis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Solid-phase Oligonucleotide Synthesis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Solid-phase Oligonucleotide Synthesis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Solid-phase Oligonucleotide Synthesis revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Solid-phase Oligonucleotide Synthesis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Solid-phase Oligonucleotide Synthesis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Solid-phase Oligonucleotide Synthesis Overall Market Size
2.1 Global Solid-phase Oligonucleotide Synthesis Market Size: 2021 VS 2028
2.2 Global Solid-phase Oligonucleotide Synthesis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Solid-phase Oligonucleotide Synthesis Players in Global Market
3.2 Top Global Solid-phase Oligonucleotide Synthesis Companies Ranked by Revenue
3.3 Global Solid-phase Oligonucleotide Synthesis Revenue by Companies
3.4 Top 3 and Top 5 Solid-phase Oligonucleotide Synthesis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Solid-phase Oligonucleotide Synthesis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Solid-phase Oligonucleotide Synthesis Players in Global Market
3.6.1 List of Global Tier 1 Solid-phase Oligonucleotide Synthesis Companies
3.6.2 List of Global Tier 2 and Tier 3 Solid-phase Oligonucleotide Synthesis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Solid-phase Oligonucleotide Synthesis Market Size Markets, 2021 & 2028
4.1.2 Primers
4.1.3 Probes
4.1.4 Intermediate-scale Synthesis Oligos
4.1.5 Large-scale Synthesis Oligos
4.1.6 Linkers and Adaptors
4.2 By Type - Global Solid-phase Oligonucleotide Synthesis Revenue & Forecasts
4.2.1 By Type - Global Solid-phase Oligonucleotide Synthesis Revenue, 2017-2022
4.2.2 By Type - Global Solid-phase Oligonucleotide Synthesis Revenue, 2023-2028
4.2.3 By Type - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Solid-phase Oligonucleotide Synthesis Market Size, 2021 & 2028
5.1.2 Commercial
5.1.3 Academic Research
5.2 By Application - Global Solid-phase Oligonucleotide Synthesis Revenue & Forecasts
5.2.1 By Application - Global Solid-phase Oligonucleotide Synthesis Revenue, 2017-2022
5.2.2 By Application - Global Solid-phase Oligonucleotide Synthesis Revenue, 2023-2028
5.2.3 By Application - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Solid-phase Oligonucleotide Synthesis Market Size, 2021 & 2028
6.2 By Region - Global Solid-phase Oligonucleotide Synthesis Revenue & Forecasts
6.2.1 By Region - Global Solid-phase Oligonucleotide Synthesis Revenue, 2017-2022
6.2.2 By Region - Global Solid-phase Oligonucleotide Synthesis Revenue, 2023-2028
6.2.3 By Region - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028
6.3.2 US Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.3.3 Canada Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.3.4 Mexico Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028
6.4.2 Germany Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.3 France Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.4 U.K. Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.5 Italy Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.6 Russia Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.7 Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.4.8 Benelux Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028
6.5.2 China Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.5.3 Japan Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.5.4 South Korea Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.5.5 Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.5.6 India Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028
6.6.2 Brazil Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.6.3 Argentina Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028
6.7.2 Turkey Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.7.3 Israel Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.7.4 Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
6.7.5 UAE Solid-phase Oligonucleotide Synthesis Market Size, 2017-2028
7 Players Profiles
7.1 Genescript
7.1.1 Genescript Corporate Summary
7.1.2 Genescript Business Overview
7.1.3 Genescript Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.1.4 Genescript Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.1.5 Genescript Key News
7.2 GeneArt (Thermofischer)
7.2.1 GeneArt (Thermofischer) Corporate Summary
7.2.2 GeneArt (Thermofischer) Business Overview
7.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.2.4 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.2.5 GeneArt (Thermofischer) Key News
7.3 Renesas Electronics Corporation
7.3.1 Renesas Electronics Corporation Corporate Summary
7.3.2 Renesas Electronics Corporation Business Overview
7.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.3.5 Renesas Electronics Corporation Key News
7.4 DNA 2.0 (ATUM)
7.4.1 DNA 2.0 (ATUM) Corporate Summary
7.4.2 DNA 2.0 (ATUM) Business Overview
7.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.4.4 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.4.5 DNA 2.0 (ATUM) Key News
7.5 OriGene
7.5.1 OriGene Corporate Summary
7.5.2 OriGene Business Overview
7.5.3 OriGene Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.5.4 OriGene Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.5.5 OriGene Key News
7.6 BBI
7.6.1 BBI Corporate Summary
7.6.2 BBI Business Overview
7.6.3 BBI Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.6.4 BBI Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.6.5 BBI Key News
7.7 Genewiz
7.7.1 Genewiz Corporate Summary
7.7.2 Genewiz Business Overview
7.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.7.4 Genewiz Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.7.5 Genewiz Key News
7.8 Eurofins Genomics
7.8.1 Eurofins Genomics Corporate Summary
7.8.2 Eurofins Genomics Business Overview
7.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.8.4 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.8.5 Eurofins Genomics Key News
7.9 Gene Oracle
7.9.1 Gene Oracle Corporate Summary
7.9.2 Gene Oracle Business Overview
7.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.9.4 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.9.5 Gene Oracle Key News
7.10 SBS Genetech
7.10.1 SBS Genetech Corporate Summary
7.10.2 SBS Genetech Business Overview
7.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.10.4 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.10.5 SBS Genetech Key News
7.11 Bio Basic
7.11.1 Bio Basic Corporate Summary
7.11.2 Bio Basic Business Overview
7.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Major Product Offerings
7.11.4 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue in Global Market (2017-2022)
7.11.5 Bio Basic Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Solid-phase Oligonucleotide Synthesis Market Opportunities & Trends in Global Market
Table 2. Solid-phase Oligonucleotide Synthesis Market Drivers in Global Market
Table 3. Solid-phase Oligonucleotide Synthesis Market Restraints in Global Market
Table 4. Key Players of Solid-phase Oligonucleotide Synthesis in Global Market
Table 5. Top Solid-phase Oligonucleotide Synthesis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Solid-phase Oligonucleotide Synthesis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Solid-phase Oligonucleotide Synthesis Product Type
Table 9. List of Global Tier 1 Solid-phase Oligonucleotide Synthesis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Solid-phase Oligonucleotide Synthesis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Solid-phase Oligonucleotide Synthesis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Solid-phase Oligonucleotide Synthesis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Solid-phase Oligonucleotide Synthesis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Solid-phase Oligonucleotide Synthesis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2023-2028
Table 30. Genescript Corporate Summary
Table 31. Genescript Solid-phase Oligonucleotide Synthesis Product Offerings
Table 32. Genescript Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 33. GeneArt (Thermofischer) Corporate Summary
Table 34. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product Offerings
Table 35. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 36. Renesas Electronics Corporation Corporate Summary
Table 37. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product Offerings
Table 38. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 39. DNA 2.0 (ATUM) Corporate Summary
Table 40. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product Offerings
Table 41. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 42. OriGene Corporate Summary
Table 43. OriGene Solid-phase Oligonucleotide Synthesis Product Offerings
Table 44. OriGene Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 45. BBI Corporate Summary
Table 46. BBI Solid-phase Oligonucleotide Synthesis Product Offerings
Table 47. BBI Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 48. Genewiz Corporate Summary
Table 49. Genewiz Solid-phase Oligonucleotide Synthesis Product Offerings
Table 50. Genewiz Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 51. Eurofins Genomics Corporate Summary
Table 52. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product Offerings
Table 53. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 54. Gene Oracle Corporate Summary
Table 55. Gene Oracle Solid-phase Oligonucleotide Synthesis Product Offerings
Table 56. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 57. SBS Genetech Corporate Summary
Table 58. SBS Genetech Solid-phase Oligonucleotide Synthesis Product Offerings
Table 59. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
Table 60. Bio Basic Corporate Summary
Table 61. Bio Basic Solid-phase Oligonucleotide Synthesis Product Offerings
Table 62. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Solid-phase Oligonucleotide Synthesis Segment by Type in 2021
Figure 2. Solid-phase Oligonucleotide Synthesis Segment by Application in 2021
Figure 3. Global Solid-phase Oligonucleotide Synthesis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Solid-phase Oligonucleotide Synthesis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Solid-phase Oligonucleotide Synthesis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2021
Figure 8. By Type - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 12. US Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 16. Germany Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 17. France Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 24. China Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 28. India Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 30. Brazil Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue Market Share, 2017-2028
Figure 33. Turkey Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Solid-phase Oligonucleotide Synthesis Revenue, (US$, Mn), 2017-2028
Figure 37. Genescript Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. OriGene Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BBI Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genewiz Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
Solid phase Oligonucleotide Synthesis Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|